114:. Historical data can also help manufacturers better understand operational process and input variables as well as better identify true deviations from quality standards compared to false positives. Should a serious product quality issue arise, historical data would be essential in identifying the sources of errors and implementing corrective measures.
29:
production processes is essential in determining product quality because quality cannot always be determined by finished-product inspection. Process validation can be broken down into 3 steps: process design (Stage 1a, Stage 1b), process qualification (Stage 2a, Stage 2b), and continued process verification (Stage 3a, Stage 3b).
102:) are chemical, physical, biological, and microbiological attributes that can be defined, measured, and continually monitored to ensure final product outputs remain within acceptable quality limits. CQA are an essential aspect of a manufacturing control strategy and should be identified in stage 1 of process validation:
122:
In this stage, the process design is assessed to conclude if the process is able to meet determined manufacturing criteria. In this stage all production processes and manufacturing equipment is proofed to confirm quality and output capabilities. Critical quality attributes are evaluated, and critical
28:
have published guidelines relating to process validation. The purpose of process validation is to ensure varied inputs lead to consistent and high quality outputs. Process validation is an ongoing process that must be frequently adapted as manufacturing feedback is gathered. End-to-end validation of
134:
is the ongoing monitoring of all aspects of the production cycle. It aims to ensure that all levels of production are controlled and regulated. Deviations from prescribed output methods and final product irregularities are flagged by a process analytics database system. The FDA requires production
63:
is an approach to pharmaceutical manufacturing that stresses quality should be built into products rather than tested in products; that product quality should be considered at the earliest possible stage rather than at the end of the manufacturing process. Input variables are isolated in order to
75:
is used to measure critical process parameters (CPP) and critical quality attributes (CQA). PAT facilitates measurement of quantitative production variables in real time and allows access to relevant manufacturing feedback. PAT can also be used in the design process to generate a process
37:
In this stage, data from the development phase are gathered and analyzed to define the commercial manufacturing process. By understanding the commercial process, a framework for quality specifications can be established and used as the foundation of a control strategy.
106:. During this stage, acceptable limits, baselines, and data collection and measurement protocols should be established. Data from the design process and data collected during production should be kept by the manufacturer and used to evaluate
123:
process parameters taken into account, to confirm product quality. Once the process qualification stage has been successfully accomplished, production can begin. Process
Performance Qualification is the second phase of process validation.
42:
is the first of three stages of process validation. Data from the development phase is gathered and analyzed to understand end-to-end system processes. These data are used to establish benchmarks for quality and production control.
458:
51:
Design of experiments is used to discover possible relationships and sources of variation as quickly as possible. A cost-benefit analysis should be conducted to determine if such an operation is necessary.
19:
is the analysis of data gathered throughout the design and manufacturing of a product in order to confirm that the process can reliably output products of a determined standard. Regulatory authorities like
325:
146:. This alternative method of process validation is recommended by the EMA for validating processes on a continuous basis. Continuous process verification analyses
429:
240:
503:
154:
in real time to confirm production remains within acceptable levels and meets standards set by ICH Q8, Pharmaceutical
Quality Systems, and
87:
are operating parameters that are considered essential to maintaining product output within specified quality target guidelines.
131:
498:
256:
72:
177:
155:
151:
147:
84:
135:
data be recorded (FDA requirements (§ 211.180(e)). Continued process verification is stage 3 of process validation.
493:
483:
139:
21:
371:"Stage 2 Process Performance Qualification (PPQ): A Scientific Approach to Determine the Number of PPQ Batches"
488:
64:
identify the root cause of potential quality issues and the manufacturing process is adapted accordingly.
369:
Pazhayattil, Ajay; Alsmeyer, Daniel; Chen, Shu; Hye, Maksuda; Ingram, Marzena; Sanghvi, Pradeep (2016).
172:
279:"PAT - A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance"
167:
408:
Pazhayattil, Ajay Babu; Sayeed-Desta, Naheed; Fredro-Kumbaradzi, Emilija; Collins, Jordan (2018).
409:
425:
390:
370:
278:
236:
197:
60:
468:
463:
417:
382:
228:
303:
222:
111:
107:
103:
39:
477:
347:
326:"Defining Critical Quality Attributes in the Pharmaceutical Manufacturing Process"
421:
386:
232:
198:"Guidance for Industry Process Validation: Generally Principles and Practices"
394:
227:. AAPS Introductions in the Pharmaceutical Sciences. Vol. 10. 2023.
416:. AAPS Introductions in the Pharmaceutical Sciences. pp. 79–89.
453:
25:
469:
AAPS Technology
Transfer Drug Product Manufacturing Process
448:
410:"Stage 3A and Stage 3B: Continued Process Verification"
257:"A Case for Stage 3 Continued Process Verification"
8:
118:Stage 2: Process Performance Qualification
449:FDA – U.S. Food and Drug Administration
189:
127:Stage 3: Continued Process Verification
7:
348:"Critical Quality Attributes (CQA)"
259:. Pharma Manufacturing. 21 May 2014
142:defines a similar process known as
68:Process analytical technology (PAT)
414:Solid Oral Dose Process Validation
14:
91:Critical quality attributes (CQA)
80:Critical process parameters (CPP)
454:EMA – European Medicines Agency
284:. Food and Drug Administration
203:. Food and Drug Administration
132:Continued process verification
1:
73:Process analytical technology
144:ongoing process verification
504:Business process management
422:10.1007/978-3-030-02472-7_7
350:. Atris Information Systems
178:Verification and validation
156:Good manufacturing practice
152:critical quality attributes
148:critical process parameters
96:Critical quality attributes
85:Critical process parameters
520:
304:"PROCESS VALIDATION (P2V)"
47:Design of experiment (DOE)
459:Parental Drug Association
387:10.1208/s12249-015-0409-7
233:10.1007/978-3-031-32192-4
140:European Medicines Agency
464:AAPS Process Validation
56:Quality by design (QBD)
33:Stage 1: Process Design
328:. GXP-CC. 15 July 2014
173:Process qualification
499:Enterprise modelling
306:. Validation Online
224:Technology Transfer
168:Cleaning validation
17:Process validation
431:978-3-030-02471-0
375:AAPS Pharmscitech
242:978-3-031-32191-7
61:Quality by design
511:
494:Software quality
484:Software testing
436:
435:
405:
399:
398:
366:
360:
359:
357:
355:
344:
338:
337:
335:
333:
322:
316:
315:
313:
311:
300:
294:
293:
291:
289:
283:
275:
269:
268:
266:
264:
253:
247:
246:
219:
213:
212:
210:
208:
202:
194:
519:
518:
514:
513:
512:
510:
509:
508:
474:
473:
445:
440:
439:
432:
407:
406:
402:
368:
367:
363:
353:
351:
346:
345:
341:
331:
329:
324:
323:
319:
309:
307:
302:
301:
297:
287:
285:
281:
277:
276:
272:
262:
260:
255:
254:
250:
243:
221:
220:
216:
206:
204:
200:
196:
195:
191:
186:
164:
129:
120:
112:process control
108:product quality
93:
82:
76:qualification.
70:
58:
49:
35:
12:
11:
5:
517:
515:
507:
506:
501:
496:
491:
489:Formal methods
486:
476:
475:
472:
471:
466:
461:
456:
451:
444:
443:External links
441:
438:
437:
430:
400:
381:(4): 829–833.
361:
339:
317:
295:
270:
248:
241:
214:
188:
187:
185:
182:
181:
180:
175:
170:
163:
160:
128:
125:
119:
116:
104:process design
92:
89:
81:
78:
69:
66:
57:
54:
48:
45:
40:Process design
34:
31:
13:
10:
9:
6:
4:
3:
2:
516:
505:
502:
500:
497:
495:
492:
490:
487:
485:
482:
481:
479:
470:
467:
465:
462:
460:
457:
455:
452:
450:
447:
446:
442:
433:
427:
423:
419:
415:
411:
404:
401:
396:
392:
388:
384:
380:
376:
372:
365:
362:
349:
343:
340:
327:
321:
318:
305:
299:
296:
280:
274:
271:
258:
252:
249:
244:
238:
234:
230:
226:
225:
218:
215:
199:
193:
190:
183:
179:
176:
174:
171:
169:
166:
165:
161:
159:
157:
153:
149:
145:
141:
136:
133:
126:
124:
117:
115:
113:
109:
105:
101:
97:
90:
88:
86:
79:
77:
74:
67:
65:
62:
55:
53:
46:
44:
41:
32:
30:
27:
23:
18:
413:
403:
378:
374:
364:
352:. Retrieved
342:
330:. Retrieved
320:
308:. Retrieved
298:
286:. Retrieved
273:
261:. Retrieved
251:
223:
217:
205:. Retrieved
192:
143:
137:
130:
121:
99:
95:
94:
83:
71:
59:
50:
36:
16:
15:
354:10 November
332:10 November
310:22 November
288:10 December
263:22 November
207:16 December
478:Categories
184:References
395:26349690
162:See also
428:
393:
239:
282:(PDF)
201:(PDF)
426:ISBN
391:PMID
356:2014
334:2014
312:2014
290:2014
265:2014
237:ISBN
209:2014
150:and
138:The
110:and
24:and
418:doi
383:doi
229:doi
100:CQA
26:FDA
22:EMA
480::
424:.
412:.
389:.
379:17
377:.
373:.
235:.
158:.
434:.
420::
397:.
385::
358:.
336:.
314:.
292:.
267:.
245:.
231::
211:.
98:(
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.